Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Despite these numbers, GLP-1 drugs account for relatively small shares of total Medicaid spending and prescriptions, the report noted -- about 0.5% of all Medicaid prescriptions and 3.7% of gross Medicaid spending
10.1038/s41580-022-00542-2 Nat
Potential New Respiratory Treatment Researchers propose GLP-1 agonists should be further studied and considered as a therapeutic option for respiratory diseases in people with obesity
Key research areas include: Endocrine: GH secretion modulation, GHRH receptor activation
Oversight transforms uncertainty into confidence
Tan says the 12 percent increase in gout risk reported in the study is a significant increase. Its possible GLP-1s could lead to temporary changes in uric acid level because of shifting fat-muscle ratios, she says
US$ 22.75
US$ 23.91
US$ 27.21
US$ 21.33
US$ 28.64
US$ 24.57
US$ 22.78
US$ 29.05
